EAST WINDSOR, N.J.--(BUSINESS WIRE)--NexMed, Inc. (Nasdaq: NEXM), a developer of innovative transdermal products based on its proprietary NexACT® drug delivery technology, today announced that Mark Westgate, Chief Financial Officer, will present an overview of the Company at the Collins Stewart 4th Annual Growth Conference at the Mandarin Oriental Hotel in New York City on Thursday, July 10, 2008 at 10 am Eastern Time.
